Related Experiment Videos
Signaling and effector pathways
U Müller-Ladner1, R E Gay, S Gay
1Department of Internal Medicine I, University of Regensburg, Germany.
Abstract:
There is increasing evidence that distinct signaling and effector pathways in the rheumatoid synovium result in a cascade of pathophysiologic events. These interactions, which finally lead to progressive joint destruction, are different from all other joint diseases in numerous aspects. As outlined in this review, molecular biology techniques allow detection of key pathways ranging from external stimuli to subcellular gene regulation mechanisms operative in various cells within the rheumatoid synovium. To alter these pathways, inhibitory factors need to be applied to these "hot zones" for an extended period, which can be achieved either by repeated drug administration or by local synthesis using genetically altered synovial cells. Both adenovirus and retroviral constructs, as well as ex vivo and in vivo strategies, can be used for gene transfer into these cells, and routine delivery of "protective" genes into the affected joints might be achieved within the next decade.
Insights
Rheumatoid synovium involves complex pathways leading to joint destruction. Gene therapy offers a promising future for delivering protective genes to affected joints, potentially halting disease progression.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Rheumatoid synovium exhibits unique signaling and effector pathways driving progressive joint destruction.
- These pathophysiologic events differ significantly from other joint diseases.
Purpose of the Study:
- To review molecular biology techniques for detecting key pathways in rheumatoid synovium.
- To explore strategies for altering these pathways using inhibitory factors and gene transfer.
Main Methods:
- Utilizing molecular biology techniques to identify signaling and gene regulation mechanisms.
- Investigating gene transfer methods including adenovirus and retroviral constructs.
- Considering both ex vivo and in vivo gene delivery strategies.
Main Results:
- Molecular biology enables detection of critical pathways from external stimuli to subcellular gene regulation.
- Inhibitory factors can be delivered via repeated drug administration or local synthesis.
- Gene transfer into synovial cells is achievable through various viral constructs and strategies.
Conclusions:
- Targeting specific pathways in the rheumatoid synovium is crucial for disease intervention.
- Gene therapy holds potential for sustained delivery of protective genes to affected joints.
- Routine gene delivery for rheumatoid arthritis treatment may be feasible within the next decade.